Mathias Locher

No open positions remaining

Health Technology

Consumer Services

Profile

Mathias Locher is currently the Chief Development Officer at Covagen AG.
Previously, he held the position of Vice President-PreClinical Development at Micromet AG.
From 2007 to 2011, he worked at Merck Serono SA as the Global Head-Drug Metabolism & Pharmacokinetics.
He also served as the Chief Development Officer at Heidelberg Pharma AG from 2021 to 2023.
Dr. Locher obtained a doctorate degree from Eberhard Karls Universität Tübingen.

Former positions of Mathias Locher

Companies	Position	End
HEIDELBERG PHARMA AG	Corporate Officer/Principal	2023-03-31
Covagen AG Covagen AG BiotechnologyHealth Technology Develops next generation protein drugs for the treatment of inflammatory diseases and cancer	Corporate Officer/Principal	2020-06-03
Merck Serono SA Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism	Corporate Officer/Principal	2010-12-31
Micromet AG Micromet AG Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs	Corporate Officer/Principal	-

See the detail of Mathias Locher's experience

Training of Mathias Locher

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mathias Locher's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Micromet AG Micromet AG Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs	Health Technology
Heidelberg Pharma AG Heidelberg Pharma AG Pharmaceuticals: MajorHealth Technology Develops cancer therapies	Health Technology
Eberhard Karls Universität Tübingen Eberhard Karls Universität Tübingen Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Merck Serono SA Merck Serono SA Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for reproductive and metabolism	Health Technology
Covagen AG Covagen AG BiotechnologyHealth Technology Develops next generation protein drugs for the treatment of inflammatory diseases and cancer	Health Technology